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Infection with pneumocystis carinii and cytomegalovirus was found in a young male
suspected of having miliary tuberculosis. Problems of diagnosis and predisposing factors for
these infections in the patient are discussed. The patient's clinical course and management are
reviewed. Autopsy findings are presented. Alternative modes of therapy are considered.
DR. LISA BABITZ (Resident in Medicine): The patient was a 43-year-old Chilean male
in the U.S. for five years. He presented to the ER with a five-week history of fatigue,
a twenty-pound weight loss, and a two-week history of productive cough, hemop-
tysis, night sweats, dyspnea, and headache. When he first presented with
malaise, his doctor performed some blood tests and a chest X-ray. All were reportedly
normal. He was seen by a second doctor who prescribed an antidepressant and
subsequently IM penicillin for a positive VDRL and a weakly positive FTA. With
the worsening of his cough and dyspnea, he saw a third physician. He was found to
have a bilateral interstitial infiltrate on chest X-ray and was sent to the ER to rule
out miliary TB.
Past medical history was remarkable for a history of a heart murmur in his
childhood, aquestion ofsyphilis, which was treated in Chile, about 18 years prior to
admission, and herpes zoster ofthe right side three years prior to admission. The pa-
tient admitted to drinking a beer aweek, but denied any"recreational" drug use. His
travel history was remarkable for 31 years spent in Chile, followed by travel in
Europe and Great Britain, and a year aboard a cruise ship. He was a sexually active
homosexual living for the past fiveyears in arural community with a weekend apart-
ment in a large city.
Physical exam revealed a cachectic white male in moderate repiratory distress with
a hacking cough. His pulse was 90/minute and regular, and his blood pressure was
120/80. His respiratory rate was 36/minute at rest, and his temperature was 99.60 F
rectally. His sclerae were anicteric. His fundoscopic exam was unremarkable. The
oropharynx was without erythema or exudate. The only adenopathy noted was a
small 1 cm mobile, non-tender, left axillary lymph node. His lungs were resonant to
percussion with clear breath sounds throughout. His cardiac exam was remarkable
for a II/VI mid-systolic murmur at the left sternal border without radiation. Normal
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All rights of reproduction in any form reserved.heart sounds with a physiologic split were heard. The abdomen was non-tender, and
there was no hepatosplenomegaly. Extremities showed no clubbing. Genital, rectal,
and neurologic examinations were unremarkable.
Laboratory studies showed a hemoglobin concentration of 13.7 gm/dl and a
hematocrit of 29.2 percent. The white blood cell count was 8100/mm3 with 76 per-
cent segmented cells, 2 percent bands, 18 percent lymphocytes, 2 percent monocytes,
and 1 percent eosinophils. His PT and PTT were within normal limits. Electrolytes
were unremarkable, BUN was 27 mg/dl, and glucose was 128 mg/dl. His urine was
clear yellow with a specific gravity of 1.030 and a pH of 5. The urine was positive
for ketones and protein by dipstick. Microscopic examination showed several white
blood cells and two red blood cells per high-powered field. His cardiogram showed
normal sinus rhythm with normal wave forms. Sputum examination did not show
any acid-fast bacilli. Spinal fluid was examined and revealed no white cells, 156 red
cells/mm3, 25 mg/dl of protein, and 17 mg/dl glucose. No organisms could be seen
on gram stain.
DR. ALAN KLIGER (Associate Professor ofMedicine): This young man presented with
fatigue, weight loss, malaise, headache, and symptoms suggesting pulmonary infec-
tion: night sweats, fever, dyspnea, hemoptysis, and a productive cough. Dr. Carter,
what was his chest X-ray like on admission?
DR. ANTHONY CARTER (Resident in Radiology): The chest film from the date of the
patient's admission shows a fine reticular pattern throughout his lungs which
obscures some of the pulmonary vasculature. He has no significant adenopathy or
calcifications, and no pulmonary effusions can be seen. His heart is of normal size.
This is a non-specific pattern, but, with the history in mind, it points away from
tuberculosis. It suggests a diffuse pneumonia, such as is seen in viral respiratory in-
fections. Fluid overload alone could appear this way, as could drug abuse. Heroin
abuse certainly could produce a pattern like this one.
DR. KLIGER: When this patient first presented, both the medical house staff and the
radiology department felt strongly that the leading diagnosis was pulmonary tuber-
culosis. The day after admission the case was presented to Dr. Richard Root of the
Infectious Disease Section, who did not agree with the diagnosis. Dr. Root, please
tell us what your thoughts were, and how you proceeded in your evaluation.
DR. RICHARD ROOT (Professor ofMedicine): My approach to this patient was aided
by my having had three similar cases presented to me two months earlier at UCLA.
Focusing on some things about the epidemiologic history in this patient, I think we
can move rapidly to a specific diagnosis. To do so I will follow my traditional ap-
proach to infectious disease cases. Namely, we must ask the following questions.
What are the epidemiologic factors in which a disease develops? What are the major
clinical manifestations? What are the host factors that one has to consider? And
how does that lead to a specific diagnostic or therapeutic measure? The host factors
that were of interest in this patient were that he really had no known underlying
disease or major disorder previously. Ofinterest in a relatively young person is that
he apparently had a spontaneous herpes zoster infection. This raised the question of
a possible decrease in his cellular immune function. From the epidemiologic stand-
point, he was from Chile, wheretuberculosis isendemic, and he had traveled all over
the world. Perhaps more importantly, he had a positive VDRL and FTA, indicating
a contact with venereal pathogens in the past, and his life style was that of a practic-
ing homosexual. This last information had been elicited on the initial history and
was presented to me somewhat as an afterthought by the fellow or resident who saw
the case with me on the ID service. The patients that had been presented to me at
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UCLA were male homosexuals with combined pneumocystis and cytomegalovirus
pneumonia. The nature of this patient's pulmonary infiltrates was somewhat
atypical for tuberculosis, with a much finer pattern, and being more reticulo-
nodual than truly miliary. One ofthe physical findings that was striking to me when
I saw the patient was that his fingers were clubbed. An old clinical saw, which
follows my personal experience, is that despite the hypoxemia that'may be induced
by pulmonary tuberculosis, it is not a disease that is regularly associated with club-
bing. If a patient with tuberculosis shows clubbing of the fingers, one should con-
sider other diagnoses to explain it. Such a patient either does not have tuberculosis,
which, as we'll find out, was the case in this patient, or he has a complication, such
as a pulmonary carcinoma or bronchiectasis, which might lead toclubbing inthe set-
ting of a previous or active tuberculosis. It is also important in the presentation of
this patient that, while the sputum was "negative for AFB," there was very little
sputum that was worth examining.
Given the range of diagnostic possibilities, the nature of the interstitial
pneumonia, and the host factors present, the possibility was very strong in my mind
that he had a pneumocystis or a cytomegalovirus infection. With these possible
diagnoses and the fact that the patient was already suffering from severe hypoxemia,
it was important to establish a diagnosis rapidly. At that point the pulmonary service
became involved in the care of the patient.
DR. KLIGER: Dr. Merrill, you saw the patient for the pulmonary service. Dr. Root
and the other consultants felt that it was important to make a diagnosis rapidly. You
have at your disposal a series of tools, including the sputum examination, en-
dotracheal aspiration, bronchoscopy with brushings and lavage, bronchial biopsy,
and open lung biopsy. In a patient who has adiffuse process such as this, what is the
best approach for a rapid diagnosis?
DR. BILL MERRILL (AssistantProfessor ofMedicine): In general, the test that I choose
depends on the patient's clinical stability at the time that he is first seen. If the pa-
tient has a room air pO2 of 40 or 50 mm Hg, and has little response to the ad-
ministered oxygen, then I think it's wise and most expeditious to go directly to an
open lung biopsy. The time delay caused by ordering other tests and analyzing them
may mean that the patient will be on a ventilator requiring a high FIO2 and high
positive end expiratory pressures (PEEP) at the time that one would like to do a fur-
ther diagnostic procedure, such as an open biopsy. This patient had a PO2 of60 mm
Hg on room air, although he did have a tremendous A-a gradient. His pCO2 was
somewhere in the 20s. He was working tremendously at breathing to maintain his
PO2, and he had a big gradient. Since he was relatively comfortable on Friday night,
we elected to do a semi-elective bronchoscopy the following Monday. On Monday
morning, after he had been treated for tuberculosis for about three days, we did a
bronchoscopy with a lavage and biopsy.
DR. KLIGER: During those initial three days the patient did not remain clinically
stable. He had high spiking fevers, and the partial pressure of oxygen in his arterial
blood declined. Anti-tuberculous therapy was begun, and, in light of Dr. Root's
thoughts, he was also treated for pneumocystis carinii with intravenous Septra
before the biopsy was performed. Dr. Root, in your opinion, was bronchoscopy re-
quired before initiation of specific therapy?
DR. ROOT: We felt strongly that one should have moved expeditiously to pursue
either bronchoscopy or open lung biopsy on this patient. We felt ifthere was to be a
delay, we certainly would start treatment for both tuberculosis and pneumocystis.
DR. KLIGER: Can we see the results of that lung biopsy?
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had a rather specific clinical diagnosis and Dr. Warren, our senior resident, felt that
she had found a specific pathogen in the tissue and asked for our confirmation. This
is the low-power view of the transbronchial lung biopsy, which, for some of you,
may be virtually unrecognizable as lung (Fig. 1). Indeed, it is a very cellular tissue,
and we'll come back to that in just a moment. Certainly, alveolar architecture is very
difficult to recognize. There is a little biopsy-induced hemorrhage which is common
to such specimens. In the proper clinical setting I would characterize this lesion as an
interstitial pneumonitis. There is epithelial proliferation and a great deal of in-
terstitial collagen proliferation, which is of extreme interest considering the course
that this patient ultimately follows. This delicate interface between acute alveolar in-
jury and organizing interstitial pneumonia in which collagen is beginning to be laid
down is something that we know very little about, either in human or experimental
models. Looking ahead, this process oforganization continued unrelentingly in this
patient. Next, looking over a high-power field we see an alveolar exudate (Fig. 2).
Those of you who remember the classic textbook pictures of pneumocystis carinii
pneumonia know that this morphology is characteristic of that disorder. The
definitive diagnosis, however, depends upon selective staining, either of intracystic
sporozoites or of the intact capsule. We chose the latter course because of its utility
and our experience with it. A silver methenomine stain shows multiple pneumocysts,
with some actually filling many ofthe alveolar structures despite the 24-hour history
of therapy (Fig. 3).
Apropos ofthe earlier question ofwhether the patient's sputum had been examined
for pneumocystis, bronchioles in the open biopsy showed masses of pneumocystis
organisms present in the small airways. Although this is not always the case with
pneumocystis, one might guess that had we examined the sputum, we might have
FIG. 1. Radiograph with bilateral diffuse in-
filtrates.
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FIG. 2. Lung tissue with
alveolar architecture oblit-
erated by inflammation and
* ~~~early fibrosis. 100 x.
seen the organisms in this particular case. The organisms in such a case are so
numerous that they will be seen regardless of the approach one uses to the lung,
whether by open lung biopsy, transthoracic aspirate, or a transbronchial approach.
In other cases of pneumocystis infection, however, the picture may resemble a
desquamative interstitial pneumonitis. In that form of pneumocystis carinii
pneumonitis, the organisms are relatively scarce, and I am less optimistic about
transbronchial or aspirate procedures yielding the diagnosis. As with most infectious
processes in the lung, a negative study will not necessarily exclude the diagnosis.
Overall, the open lung biopsy will probably continue to be the best approach for
highest yield.
DR. ROOT: Did you see any inclusion bodies on the biopsy?
DR. SMITH: No other pathogens were suspected or recognized in the transbronchial
biopsy.
DR. FRED SCHIFFMAN (Assistant Professor ofMedicine): How many days of therapy
are required to obscure or to eliminate these organisms in the lung tissue?
DR. MERRILL: There have been some clinical studies on that specific point.
Pneumocysts have been seen in lung tissue five days after therapy is started. Exactly
how long they continue to appear following the onset of therapy is unknown.
e7 .44 Ffi
4 ~f, 40
& ~~~~~~~~~T1~,,- r FIG. 3. Alveoli filled with
,lacy, foamy material char-
-. ~~~~acteristic of pneumocystis
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467DR. MARGARET BIA (Assistant Professor of Medicine): Were any of the lung
specimens sent for CMV culture?
DR. KLIGER: Cytomegalovirus pneumonia was considered in the differential
diagnosis, and cultures were obtained. Let's hear the rest of the clinical course.
DR. BABITZ: On the sixth hospital day, two days after bronchoscopy and the initia-
tion of IV Septra, the patient's pulmonary status worsened, with an FIO2 of0.5, and
a tidal volume of 850 ml. Endotracheal intubation and assisted ventilation were
begun with a positive end expiratory pressure (PEEP) of 10 mm Hg. A blood gas
determination showed a pH of 7.7, pCO2 of 43 mm Hg, and pO2 of 60 mm Hg.
Mechanical ventilation continued until his death two months later, and his course
was marked by multiple respiratory complications, a variety ofinfections, malnutri-
tion, and chronic gastrointestinal bleeding.
Shortly after intubation it became apparent that the patient required high levels of
PEEP to maintain adequate oxygenation. During the first two weeks of ventilation
the PEEP requirements increased from 10 to 16 mm Hg. Attempts were made to op-
timize his respiratory status by diuresis, and blood transfusions were given to main-
tain the oxygen-carrying capacity. However, despite these measures, the PEEP re-
quirement remained at 16 mm Hg. Eight days after intubation the patient developed
subcutaneous emphysema extending bilaterally through the chest and neck. A chest
X-ray taken at that time revealed pneumomediastinum, as well as bilateral apical
pneumothoraces which did not appear to be under tension. That evening the patient
became agitated, diaphoretic, and cyanotic, and was noted to have absent breath
sounds on the right side as well as marked hypoxia. A chest X-ray revealed a tension
pneumothorax of the right lung, which was relieved immediately by the placement
of a chest tube. His hypoxia also improved. Another chest tube was placed in one of
the left apical pneumothoraces. Two days later, peak airway pressures continued to
reach 80 mm Hg, and the patient began to have episodes of agitation and tachycar-
dia. A 50 percent right pneumothorax was seen, despite the presence of a function-
ing right-sided chest tube. A second right-sided chest tube was placed, and the pa-
tient was treated with Pavulon to decrease the peak airway pressures. He developed
multiple new pneumothoraces despite success in lowering his PEEP to 8 mm Hg.
About 13 days after intubation atracheostomy was performed. Thethird and fourth
weeks of ventilation required continual manipulations of his tidal volume,
respiratory rate, FIO2, and PEEP in order to maintain adequate oxygenation and to
keep his pCO2 within the physiologic range. It became apparent that simply increas-
ing the respiratory rate to 24/minute did not decrease his pCO2, but did decrease his
PO2. Therefore, it became necessary to tolerate pCO2's in the 50's and 60's. One
month after intubation the patient developed a tracheo-esophageal fistula. Two
months after intubation PEEP was discontinued entirely for about 24 hours, before
oxygenation necessitated its reinstitution. Two months and ten days after intubation
the patient expired, following a week of progressive hypoxia.
Several infections complicated thepatient's clinical course. Bronchoscopy cultures
were obtained four days after admission, and an atypical mycobacterium was
cultured from the specimen. It was our opinion that the mycobacterium was not a
pathogen, because it was not seen invading the tissue samples obtained on biopsy.
The patient received a two-week course of intravenous Septra, followed by two
weeks of treatment with pentamidine. On admission, the patient's CMV antibody
titer was 1:64. Three weeks after admision the CMV antibody titer was 1:128. His
sputum and urine both contained large numbers of CMV. The patient also had fre-
quent episodes of fevers and elevations of his white blood cell count. With each
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episode, all of his indwelling venous and arterial catheters were removed and
cultured, as were his blood, sputum, and urine. Four days after intubation the pa-
tient experienced a rigor and an increasing white blood cell count, and tobramycin
and mandol were administered in addition to the intravenous Septra. The fever
quickly abated, and the antibiotic therapy was changed to cefoxitin when cultures of
his sputum grew staphylococcus aureus. Two weeks after intubation, the patient
again experienced an episode of fever and leukocytosis, and budding yeast were
found in his urine and sputum. No hyphal forms were seen, but no apparent
bacterial source for the fever was found. He was treated with Amphotericin B. One
month after intubation, two blood cultures grew enterococcus, and the patient was
treated for four weeks with ampicillin and gentamicin. Five and one-halfweeks after
intubation the patient became leukopenic. His white blood cell count was 1700/mm3
with 29 percent segmented cells, 54 percent bands, 4 percent lymphocytes, 3 percent
monocytes, and 1 percent eosinophils. His platelet count was 150,000 mm3.
Antibiotic-induced bone marrow suppression was suspected, and his white blood
cell count rose when vancomycin was substituted for ampicillin. Finally, about two
months after intubation he developed a herpes zoster rash on his left flank. When
the zoster spread to his chest and arms he was treated with Ara-A.
DR. JOHN DWYER (Associate Professor ofMedicine): Elizabeth, was he treated with
steroids at any point during this?
DR. BABITZ: He received no steroids other than low doses of Solu-Cortef with each
dose of Amphotericin B.
DR. KLIGER: May we review the chest radiographs taken during the hospitalization?
DR. CARTER: A chest film taken three days after admission reveals homogenous
opacities in the left upper lobe, in the left lower lobe, and in the right upper lobe.
The previous interstitial pattern had progressed to an alveolar phase. About a week
after this he had pneumomediastinum, and developed subcutaneous emphysema
and small pneumothoraces. Another film taken a night later shows a large tension
pneumothorax on the right, with the mediastinum pushed to the left, and the right
lung compressed into a small mass. That was in early November. A chest film in early
December shows a diffuse, coarse, reticular pattern with some alveolar filling which
remained essentially unchanged over the next two months of hospitalization until
the day of his death. I might add that the initial course is fairly typical for
pneumocystis pneumonia, with the appearance of an interstitial pattern first,
followed by rapid development of an alveolar phase.
DR. KLIGER: Turning to the pulmonary management, I note that 560 arterial blood
gas determinations were made in the course ofthe less-than-100-day hospitalization.
These studies alone required a liter and a half of blood.
Bill, the patient died with multiple pulmonary complications. There were two
major issues in the pulmonary management. First is the problem of oxygen toxicity,
because this patient required increasing concentrations ofinspired oxygen. Second is
the problem of baro-trauma, because this patient suffered from pneumothoraces,
eventually requiring five chest tubes. What can we do in the future to prevent
ourselves from backing into this buzz saw?
DR. MERRILL: I think some ofthe problems that this patient had were unavoidable, in
that the initial biopsy showed fibrosis, and a variety of factors resulted in what I
imagine would be an end-stage lung. It is really unclear what role pneumocystis
played, what role viruses played, and what role oxygen toxicity played as problems.
For the first four to five days that he was in the hospital his FIO2 was never much
higher than 0.6-0.7. But there was really never any dramatic improvement, and, in
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sure, and, finally, increasing levels of F102 to maintain oxygen delivery. Terminally
he had many problems with both baro-trauma and a tracheo-esophageal fistula
which were recognized by the physicians caring for him. There are some experimen-
tal ventilatory techniques that might have prevented these things and made subse-
quent management, once complications developed, a little easier, such as high-
frequency ventilation [1,2]. None of them were available in this hospital, and,
therefore, I think that, practically, there was not much that we could have done to
prevent it.
DR. KLIGER: Can we see the pathology now?
DR. SMITH: Perhaps someone might comment on the efficacy of steroids early on in
this particular patient. He did have evidence of early organization in the biopsy. As
Dr. Merrill has suggested, the lungs did progress to end-stage, and they were ex-
traordinary at autopsy.
The autopsy was performed by Dr. Nolan Core, who described the lungs as
weighing 2,060 and 1,330 grams, right and left, respectively. The lung, radiograph-
ically, was a "white out"; pathologically it is a"white out" as well, with fibrous tissue
seen everywhere (Fig. 4). In the upper lobe are abscesses which relate best to the
tracheo-esophageal fistula. I can summarize the microscopy of this lung with very
few words, because fibrous tissue is proliferating throughout and filling alveoli and
bronchioles. In some fields epithelial proliferation and metaplasia were predominate.
While Dr. Merrill has suggested that this fibrosis could be attributed to a number of
factors, with which I would agree, the feature of bronchiolitis in this case suggests
that perhaps oxygen toxicity did play a major role. Two pathogens were found that
may have helped produce the fibrosis. Inclusions diagnostic for cytomegalovirus
were seen in virtually all microscopic fields ofthe lung. There was residual pneumo-
cystis infection, although in sections stained with silver methenomine, the organisms
were less numerous than in the biopsy.
Last, but not least, this patient developed an esophageo-tracheal fistula in the
final weeks ofhis life. The fistula, as seen from the esophageal side, measured 4 x 2
cm in greatest dimension. While widespread necrotizing pneumonia and gross
abscesses resulted from the fistula, it was present long enough to contribute to the
diffuse lung fibrosis.
In summary, we see an end-stage lung due to multiple factors. Possibly, the
Tf' 'V's-1
bv .~~~
large numbers of pneumo-
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FIG. 5. Fibrotic lung from autopsy.
pneumocystis, as suggested by the original biopsy, and, certainly, cytomegalovirus
infection contributed to an organizing interstitial pneumonitis. Therapy may have
significantly accentuated the process. Oxygen toxicity and respiratory care which led
to the complication of atracheo-esophageal fistula were additional insults leading to
lung fibrosis.
DR. ROOT: Did the patient have endocarditis?
DR. SMITH: No, there was no evidence of endocarditis.
DR. KLIGER: This patient had pneumocystic pneumonia, CMV infection, and several
bacterial infections as well. Dick, what was the light that went on in your head, and
why did you come to this diagnosis so quickly?
DR. ROOT: The cases that were presented to me at UCLA were later published along
with a series from other institutions [3-6]. In these papers a syndrome was described
which occurs in either homosexual males or in addicts, particularly those who use
amyl nitrate as one oftheir "recreational" drugs. The number and type of infections
in these cases have been striking. The common denominator has been CMV, but
pneumocystis has been very common in these patients. Some of them had atypical
mycobacterial infections, often recognized as a postmortem finding. Infection by
candida species has been prominent as the cause of either mucous membrane lesions
or disseminated disease in these patients. Bacterial infections have also been promi-
nent. As in this patient, it is difficult to know whether these are simply a manifesta-
tion of the "nosocomial state," in which the body is invaded by a series of tubes and
catheters, or whether they represent a specific example of an immunologically in-
duced defect in host resistance. The admitting leukocyte count in this patient was
8,000/mm3. The differential included 18 percent lymphocytes, giving him about
1,400 lymphocytes/mm3. That is just on the borderline low side of normal. The
common feature seen in all of these patients is a severe immunologic defect,
presumably induced by the cytomegalovirus infection. The other infectious com-
plications, namely that of intracellular-type organisms, occur as a consequence of
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tients to eradicate the cytomegalovirus, immunosuppression persists, and the
number and type of infections multiply. Ultimately, in the 160 cases reported to the
CDC, there has been a mortality rate of 60-70 percent.
The first key to the early management ofthese patients is to recognize that the ap-
propriate conditions exist for these infectious complications to occur. Second, one
must rapidly attempt to establish the cause of diffuse pulmonary infiltrates. With
respect to the profound nature of the immunosuppression, I would emphasize that
60 days after stopping appropriate treatment for pneumocystis in this patient, there
was still evidence of at least the cyst forms of the organisms persisting in his lungs.
Findings of this type, and relapses with active infections, lead to the recommenda-
tion that following a therapeutic course of trimethaprim and sulfamethoxasole, or
of pentamidine, one should continue with prophylactic treatment against these
organisms in such patients. Retrospectively, it would have been appropriate to have
actually initiated therapy for pneumocystis pneumonia the night that we first saw
him, rather than waiting for a 48-hour period. Such treatment would not have
altered the possibility of establishing the diagnosis within that time. Whether this
would have made a major difference in his outcome, given the fact that he already
had evidence ofchronic lung injury at the time he had alungbiopsy, is conjectural, I
think, at best.
Finally, I think there are two critical questions that could be answered by
members of the audience. Frank Bia, is there anything specifically available at the
present time to eradicate CMV or to reduce its clinical manifestations?
DR. FRANK BIA (Assistant Professor ofMedicine and Lab Medicine): There are an-
tiviral agents, such as Ara A (adenine arabinoside), which are available. Some ofthe
house officers have treated other herpes infections with it. Of all the herpes viruses,
CMV seems to respond the least to Ara A, and, therefore, it is not indicated for
treatment of CMV infections. A new agent, Acyclovir (acycloguanosine), has ex-
cellent activity against herpes viruses. However, groups which have evaluated that
drug against CMV do not see that it has efficacy.
This association of CMV interstitial pneumonia and pneumocystis infection is not
new. It is new, it seems, in this particular population. Bone-marrow transplantation
patients have been developing interstitial pneumonia over the past five years. CMV
was the causative agent in many of these patients, and often it was associated with
pneumocystis.
We have not come up with any other treatments yet, but there are two
possibilities. One, is the use of interferon. Interferon, of course, is not a viral-
specific drug. It works on the host, producing effects on many different viruses.
There is some evidence that interferon will be of use in patients who have CMV in-
fections. There is currently a patient from the Philippines in the hospital now who
has CMV retinitis. He lost one eye, and is on an interferon therapy protocol. The
other possibility, which I believe you mentioned was tried in this patient, is the use
of transfer factor. I have no experience with it.
Given this particular situation, I'd say that none of the available antiviral agents
would have a beneficial effect on CMV, except perhaps interferon.
DR. ROOT: So, currently available therapy directed specifically against the organism
that we believe to be responsible for the immunologic deficiency syndrome is either
untried or not efficacious. This leaves us to consider the other factors that might re-
quire management in such patients. What is the nature of the immunosuppression
produced in these patients, and how can one approach this therapeutically? Could
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we, perhaps, have helped to produce a different outcome? For that John Dwyer will
have the final word.
DR. DWYER: We studied the lymphocytes from this patient's blood in November, by
which time his cell-mediated immunity was severely suppressed. We measured the
response of his lymphocytes to phytohemagglutinin (PHA) and his ability to re-
spond to both candida, as an antigen, and allogeneic cells. There was virtually no
response to either of these antigenic stimuli. As we were not aware at the time of the
clinical details of the case, we did not look at his suppressor cell function, which we
would normally do in such a case. Similarly, it would have been appropriate to have
studied his immune capacity, if any, to antigens associated with the various herpes
viruses, as well as to tuberculin. I can only guess, therefore, at the likely sequence of
events in this patient.
The active homosexual life of this patient obviously holds some clue to the
etiology of his immunosuppression, but it is difficult to be certain of the mechanism
involved. The literature appearing on this subject would suggest that there is some
relationship between the number of sexual partners taken and the degree of im-
munosuppression that is induced. It is intriguing to try to speculate on the im-
munological mechanisms that may be responsible. Clearly both sperm and seminal
fluid are antigenic, and it is possible that a form of immunosuppression known as
antigenic competition is set up when numerous different sperm or seminal fluid an-
tigens enter the lower part of the intestinal tract. Antigenic competition is a well-
known phenomenon in which exposure to one antigen, either simultaneously with,
or prior to exposure to another antigen, may lead to an inadequate, and, in fact,
almost absent humoral and/or cell-mediated immune response to the second an-
tigen. A number of animal models have been studied which show that it is par-
ticularly easy to produce tolerance to certain antigens that are first encountered
through the intestinal tract. Both specific and non-specific immunosuppression can
be achieved in this manner. The tolerance that develops may well have to do with
processing of antigens absorbed in the intestinal tract by the Kupffer cells in the
liver, which may present antigens to lymphocytes in a tolerogenic fashion. Alter-
natively, or perhaps compounding the problem, cytomegalovirus entering the in-
testinal tract may play a major role in extending the degree of immunosuppression
already present. CMV can be isolated from many biological fluids in an infected pa-
tient, and it is certainly conceivable that it may enter the lower intestinal tract in
seminal fluid. This virus, like EB virus, is able to produce gross disturbances of im-
mune function in humans, and it appears to exert its major influence by causing a
polyclonal B-cell expansion that triggers off immunosuppressive mechanisms that
exert a non-specific effect on inflammation-producing T cells. Consequently,
already weakened defenses to the microorganisms normally handled by effector T
cells will become even less efficient. Certainly the infectious disease problems il-
lustrated in this case read like a textbook list of problems likely to occur in
somebody who is grossly T-cell deficient. As we have seen many patients with this
syndrome, the above hypotheses should be testable in the near future.
We have just seen, in fact, a very similar case to the one under discussion, in
which, before the results of open lung biopsy were known, his leading differential
diagnosis was that of hypersensitivity pneumonitis. Because of the severe nature of
his pulmonary infiltrate, he was started on steroids after the lung biopsy and im-
proved in a dramatic fashion. Pulmonary function studies, his chest X-ray, and his
well-being all responded promptly. When the biopsy was read, it was discovered that
he had a pneumocystis carinii infection, and it seems very likely that some of the in-
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tient under discussion, were blocked in this earlier patient by the administration of
steroids. I feel that we should seriously consider using steroids together with anti-
pneumocystis therapy at an early stage in a number of cases. The beneficial effects
of steroids may in fact be more than simply anti-inflammatory, as certain sup-
pressor-cell mechanisms are selectively sensitive to steroids and so, inappropriate
activity in this area may be dampered down by the administration ofthese agents. In
the future, it may not seem surprising to be using low doses of drugs, such as
cyclophosphamide, which selectively interferes with suppressor cells, to treat im-
munodeficient states.
DR. KLIGER: Would treatment with transfer factor have been helpful here?
DR. DWYER: We would have advised treatment with transfer factor for this patient.
We have been administering transfer factor for the management of a number of in-
fectious disease problems for the last ten years and have had some very encouraging
experiences. In general, however, transfer factor has not been regarded too
favorably in the literature until the recent past. Now it is experiencing a rebirth of
respectability because of the clear-cut demonstration that antigen-specific transfer
factor is indeed able to transfer immunity to a number of microorganisms and that
this appears to apply to the herpes virus group, as well as a number of fungal and
mycobacterial antigens. A control study has been reported in which the administra-
tion of transfer factor, obtained from donors immune to varicella, to children with
acute lymphocytic leukemia prior to chemotherapy almost totally blocked the nor-
mally high incidence of opportunistic varicella infection that develops in these
children. There is evidence that one can modify the course of an established infec-
tion with herpes virus by the administration of transfer factor. As this material in-
duces reactivity amongst the recipient lymphocytes and is not directly im-
munologically active, it is obviously necessary to give the drug before there has been
a gross reduction in the number of circulating lymphocytes.
DR. KLIGER: The published cases of male homosexuals, drug abusers, or patients
with Kaposi's sarcoma who have complicating CMV or pneumocystis infections
describe the presence of skin anergy and profoundly low levels of circulating lym-
phocytes. In particular, T lymphocytes are depleted, and their function is impaired.
While our patient's count was decreased, it was not in the profoundly low range of
the reported cases. In addition, the initial PPD was negative, but the control skin
test was positive. The patient apparently did not have skin anergy. Do you have any
thoughts to explain how a patient who seemed to have intact cell-mediated immunity
could go on to this devastating disease?
DR. DWYER: I did not see the delayed hypersensitivity skin testing at the time it was
done, nor am I sure of the antigen that was used in association with the tuberculin.
If it was candida albicans, a positive result would certainly be puzzling, given this
patient's total lack ofability to respond to this antigen in tissue culture. On the other
hand, if he remained sensitive to other ubiquitous antigens, but was unresponsive to
antigen that he had only recently experienced (for example, tuberculin), this would
not be all that unusual. We know that if one has been previously sensitized to an an-
tigen and is developing severe immunosuppression to the point ofbecoming anergic,
he will lose the capacity to respond at the T-cell level to an antigen which he has not
yet experienced before he loses the ability to respond to an antigen to which he has
been previously sensitized. The fact that thispatient's lymphocyte count was respect-
able at the time of his initial presentation and that it rapidly fell, indicates the need
for some urgency in the work-up and immunological manipulation of patients with
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this form of problem. There are always some dangers in extrapolating from lym-
phocyte count in the peripheral blood, as it is possible that gross alterations in the
migratory patterns ofTlymphocytes may result in a gross deficiency ofTcells in the
peripheral blood, while normal numbers may be present in the lymph nodes and
spleen, etc. Probably, therefore, it is reasonable in most of these patients, even if
they are severely lymphopenic, to try therapy with an agent such as transfer factor.
Unfortunately, inthis particular case, I cannot be any more specific as to the reasons
for the apparent anomalies you mention.
PHYSICIAN: I have aquestion promptedby Dr. Root's mention ofamyl nitrate. What
is known about "recreational" drugs that are widely used in the homosexual popula-
tions, such as amyl, butyl, and propyl nitrates, in terms of their effects on the im-
mune system?
DR. ROOT: The immunosuppressive effect of amyl nitrate has been proposed as a
possible factor in these infections in recent months [7,8].
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